Identifying high risk features and genomic instability in men with familial prostate cancer

被引:0
|
作者
Risbridger, G. [1 ]
Sliwinski, A. [2 ,3 ]
Thorne, H. [4 ,5 ,6 ,9 ,10 ]
Taylor, R. [7 ]
Papargiris, M. [1 ]
Hunter, S. [8 ]
Campbell, I. [8 ]
Thorne, H. [4 ,5 ,6 ,9 ,10 ]
Li, J. [11 ,12 ]
Mitchell, G. [9 ,13 ,14 ,15 ]
Clouston, D. [16 ]
Bristow, R. [17 ]
Murphy, D. [18 ,19 ,20 ]
Frydenberg, M. [21 ,22 ,23 ]
Bolton, D. [24 ]
机构
[1] Monash Univ, Anat & Dev Biol, Melbourne, Vic 3004, Australia
[2] Univ Melbourne, Austin Hosp, KConFab, Res Dept, Melbourne, Vic, Australia
[3] Univ Melbourne, Austin Hosp, KConFab, Dept Urol, Melbourne, Vic, Australia
[4] Univ Melbourne, kConFab, Melbourne, Vic, Australia
[5] Univ Melbourne, Sir Peter MacCallum Canc Ctr, Dept Oncol, Melbourne, Vic, Australia
[6] Res Dept, KConFab, Melbourne, Vic, Australia
[7] Monash Univ, Dept Physiol, Melbourne, Vic 3004, Australia
[8] Canc Genet Lab, Melbourne, Vic, Australia
[9] kConFab, Melbourne, Vic, Australia
[10] Res Dept, Familial Canc Ctr, Melbourne, Vic, Australia
[11] Univ Melbourne, Bioinformat, Melbourne, Vic, Australia
[12] Univ Melbourne, GSir Peter MacCallum Canc Ctr, Res & Dept Oncol, Melbourne, Vic, Australia
[13] Univ Melbourne, Familial Canc Ctr, Melbourne, Vic, Australia
[14] Univ Melbourne, Sir Peter MacCallum Canc Ctr, Res Dept, Melbourne, Vic, Australia
[15] Univ Melbourne, Dept Oncol, Melbourne, Vic, Australia
[16] Tissupath, Melbourne, Vic, Australia
[17] Princess Margaret Canc Ctr, Toronto, ON, Canada
[18] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[19] Epworth HealthCare, Div Canc Surg, Melbourne, Vic, Australia
[20] Epworth HealthCare, Melbourne, Vic, Australia
[21] Univ Melbourne, Sir Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[22] Monash Univ, Monash Med Ctr, Dept Oncol, Melbourne, Vic 3004, Australia
[23] Monash Univ, Monash Med Ctr, Dept Urol, Melbourne, Vic 3004, Australia
[24] Univ Melbourne, Austin Hosp, Dept Urol, Melbourne, Vic, Australia
关键词
D O I
10.1016/S0959-8049(16)31388-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2569
引用
收藏
页码:S500 / S501
页数:2
相关论文
共 50 条
  • [31] SPOP mutation leads to genomic instability in prostate cancer
    Boysen, Gunther
    Barbieri, Christopher E.
    Prandi, Davide
    Chae, Sung-Suk
    Nataraj, Srilakshmi
    Blattner, Mirjam
    Marotz, Clarisse
    Xu, Limei
    Lecca, Paola
    Chhangawala, Sagar
    Zou, Pengbo
    Sboner, Andrea
    Demichelis, Francesca
    Houvras, Yariv
    Rubin, Mark A.
    CANCER RESEARCH, 2015, 75
  • [32] Bad neighbours: hypoxia and genomic instability in prostate cancer
    Ashton, Jack
    Bristow, Robert
    BRITISH JOURNAL OF RADIOLOGY, 2020, 93 (1115):
  • [33] Genomic instability and circulating tumor cells in prostate cancer
    Mai, Sabine
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 : S192 - S196
  • [34] Risk Communication and Prostate Cancer: Identifying Which Summary Statistics Are Best Understood by Men
    Ilic, Dragan
    Murphy, Kerry
    Green, Sally
    AMERICAN JOURNAL OF MENS HEALTH, 2012, 6 (06) : 497 - 504
  • [35] PCR-free method detects high frequency of genomic instability in prostate cancer
    Makridakis, Nick M.
    Phipps, Troy
    Srivastav, Sudesh
    Reichardt, Juergen K. V.
    NUCLEIC ACIDS RESEARCH, 2009, 37 (22) : 7441 - 7446
  • [36] PCR-free approach detects high rate of genomic instability in prostate cancer
    Makridakis, Nick
    Srivastav, Sudesh
    Reichardt, Juergen
    CANCER RESEARCH, 2009, 69
  • [37] Ten years national research project"familial prostate cancer" Problems in identifying risk families
    Herkommer, K.
    Schmidt, C.
    Gschwend, J. E.
    UROLOGE, 2011, 50 (07): : 813 - 820
  • [38] Healthy dietary patterns and risk of prostate cancer in men at high genetic risk
    Zhang, Yiwen
    Stopsack, Konrad H.
    Song, Mingyang
    Mucci, Lorelei A.
    Liu, Binkai
    Penney, Kathryn L.
    Tabung, Fred K.
    Giovannucci, Edward
    Plym, Anna
    INTERNATIONAL JOURNAL OF CANCER, 2024, 155 (01) : 71 - 80
  • [39] Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier
    Jeffrey J. Tosoian
    Samuel R. Birer
    R. Jeffrey Karnes
    Jingbin Zhang
    Elai Davicioni
    Eric E. Klein
    Stephen J. Freedland
    Sheila Weinmann
    Bruce J. Trock
    Robert T. Dess
    Shuang G. Zhao
    William C. Jackson
    Kosj Yamoah
    Alan Dal Pra
    Brandon A. Mahal
    Todd M. Morgan
    Rohit Mehra
    Samuel Kaffenberger
    Simpa S. Salami
    Christopher Kane
    Alan Pollack
    Robert B. Den
    Alejandro Berlin
    Edward M. Schaeffer
    Paul L. Nguyen
    Felix Y. Feng
    Daniel E. Spratt
    Prostate Cancer and Prostatic Diseases, 2020, 23 : 646 - 653
  • [40] Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier
    Tosoian, Jeffrey J.
    Birer, Samuel R.
    Karnes, R. Jeffrey
    Zhang, Jingbin
    Davicioni, Elai
    Klein, Eric E.
    Freedland, Stephen J.
    Weinmann, Sheila
    Trock, Bruce J.
    Dess, Robert T.
    Zhao, Shuang G.
    Jackson, William C.
    Yamoah, Kosj
    Dal Pral, Alan
    Mahal, Brandon A.
    Morgan, Todd M.
    Mehra, Rohit
    Kaffenberger, Samuel
    Salami, Simpa S.
    Kane, Christopher
    Pollack, Alan
    Den, Robert B.
    Berlin, Alejandro
    Schaeffer, Edward M.
    Nguyen, Paul L.
    Feng, Felix Y.
    Spratt, Daniel E.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2020, 23 (04) : 646 - 653